Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in Canada
Ryan Mee, CEO of Fulcrum Metals, reviews FY23 and progress on the Gold Tailings Hub in CanadaView Video
Roundtable Discussion; The Future of Mineral Sands
Roundtable Discussion; The Future of Mineral SandsView Video

Latest Share Chat

UK Shareholder Meetings Calendar - Next 7 Days

Fri, 11th May 2018 16:08

Monday 14 May
Centrica
Midwich Group
Safecharge International Group
Tuesday 15 May
Amerisur Resources
Macfarlane Group
Spirax-Sarco Engineering
Anglo Pacific Group
Charles Taylor
Vitec Group
IWG
UBM
Cairn Energy
G4S
Wednesday 16 May
Indivior
National Express Group
Mondi
Merchants Trust
Premier Oil
Chesnara
Jupiter Fund Management
Moss Bross
Coats Group
Ophir Energy
Cineworld Group
Tritax Big Box REIT
Secure Trust Bank
Charter Court Financial Services Group 
Utilitywise
Fenner (re acquisition by Michelin)
Thursday 17 May
Just Group
Hill & Smith Holdings
Lidco Group
Fevertree Drinks
Highcroft Investments
esure Group
Foxtons Group
Hiscox
Prudential
Next
North Midland Construction
Legal & General Group
Vectura Group
Regional REIT
Staffline Group
Robert Walters
Genel Energy
TI Fluid Systems
Friday 18 May
Paddy Power Betfair
Independent News & Media
AstraZeneca
Computacenter
Clarke (T)
Petrofac
John Menzies
Derwent London 
Hikma Pharmaceuticals
NEX Group (re acquisition by CME London)
 

Related Shares

More News
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for pr...

2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood canc...

29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negoti...

29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while a...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.